Synthesis and anti-cancer activity of some novel C-17 analogs of ursolic and oleanolic acids

Medicinal Chemistry Research

Volumn 22, Issue 3, 2013, Pages 1263-1269

  Mallavadhani, Uppuluri V ^a   Mahapatra, Anita ^b   Pattnaik, Banita ^a   Vanga, Nagireddy ^a   Suri, Nitasha ^c   Saxena, Ajit K ^c  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER AHMEDABAD   (India)

^c CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Anti cancer activity; Oleanolic acid; Triterpenic acid analogs; Ursolic acid

Indexed keywords

3 BETA HYDROXY OLEAN 12 EN 28 ALLYLATE; 3 BETA HYDROXY OLEAN 12 EN 28 METHYL ACETOACETATE; 3 BETA HYDROXY OLEAN 12 EN 28 PRENYLATE; 3 BETA HYDROXY OLEN 12 EN 28 PROPARGYLATE; 3 BETA HYDROXY URS 12 EN 28 ALLYLATE; 3 BETA HYDROXY URS 12 EN 28 METHYL ACETOACETATE; 3 BETA HYDROXY URS 12 EN 28 PRENYLATE; 3 BETA HYDROXY URS 12 EN 28 PROPARGYLATE; BROMOBUTYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMODODECYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMOETHYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMOHEXYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMOMETHYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMONONYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMOOCTYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMOPENTYL 3 BETA HYDROXY URS 12 EN 28 OATE; BROMOPROPYL 3 BETA HYDROXY URS 12 EN 28 OATE; ESTER DERIVATIVE; OLEANOLIC ACID; UNCLASSIFIED DRUG; URSOLIC ACID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL;

EID: 84874111101     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-012-0106-y     Document Type: Article

References (21)

1. Ahmad VU, Rahman AU (1994) Handbook of natural products data, vol 2: Pentacyclic triterpenoids. Elsevier, New York, p 196 & 770
2. Cos P, Maes L, Berghe DV, Hermans N, Pieters L, Vlietinck A (2004) Plant substances as anti-HIV agents selected according to their putative mechanism of action. J Nat Prod 67:284-293
3. Dzubak P, Hajduch M, Vydra D, Hustova A, Kvasnica M, Biedermann D, Markova L, Urbanc M, Sarek J (2006) Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep 23:394-411
4. Grabley S, Sattler I (2003) Natural products for lead identification: nature is a valuable resource for providing tools, chapter 5. In: Hillisch A, Hilgenfeld R (eds) Modern methods of drug discovery, Birkhauser Verlag, Basel, pp 87-107
5. Ikeda Y, Murakami A, Ohigashi H (2008) Ursolic acid: an anti- and pro-inflammatory triterpenoids. Mol Nutr Food Res 52:26-42
6. Ishihara M, Sakagami H, Liu W-K (2005) Quantitative structure- cytotoxicity relationship analysis of betulinic acid and its derivatives by semi-empirical molecular-orbital method. Anticancer Res 25:3951-3956
7. Jäger S, Trojan H, Kopp T, Laszczyk MN, Scheffler A (2009) Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts. Molecules 14:2016-2031
8. Kwon TH, Lee B, Chung SH, Kim DH, Lee YS (2009) Synthesis and NO production inhibitory activities of ursolic acid and oleanolic acid derivatives. Bull Korean Chem Soc 30:119-123
9. Laszczyk MN (2009) Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy. Planta Med 75:1549-1560
10. Lee KH (2010) Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach. J Nat Prod 73:500-516
11. Liu J (2005) Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol 100:92-94
12. Ma C, Nakamura N, Miyashiro H, Hattori M, Shimotohno K (1998) Inhibitory effects of ursolic acid derivatives from Cynomorium songaricum, and related triterpenes on human immunodeficiency viral protease. Phytother Res 12:138-142
13. Ma C-M, Cai S-Q, Cui J-R, Wang R-Q, Tu P-F, Hattori M, Daneshtalab M (2005) The cytotoxic activity of ursolic acid derivatives. Eur J Med Chem 40:582-589
14. Mallavadhani UV, Panda AK, Rao YR (2001) Diospyros melanoxylon leaves: a rich source of pentacyclic triterpenes. Pharm Biol 39:20-24
15. Meng YQ, Liu D, Cai LL, Chen H, Cao B, Wang YZ (2009) The synthesis of ursolic acid derivatives with cytotoxic activity and investigation of their preliminary mechanism of action. Bioorg Med Chem 17:848-854
16. Monks A, Scudiero D, Skehan P, Shoemaker R, Paul K, Vistica D, Hose C, Langley J, Cronise P, Vaigro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83:757-766
17. Pathak A, Singh SK, Biabani Farooq MA, Kulshreshtha DK, Puri SK, Srivastava S, Kundu B (2002) Synthesis of combinatorial libraries based on terpenoid scaffolds. Comb Chem High Throughput Screen 5:241-248
18. Shyu MH, Kao TC, Yen GC (2010) Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and down regulation of XIAP. J Agric Food Chem 58:6110-6118
19. Tian Z, Lin G, Zheng RX, Huang F, Yang MS, Xiao PG (2006) Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana. World J Gastroenterol 12:874-879
20. Yadav VR, Prasad S, Sung B, Ramaswamy K, Aggarwal BB (2010) Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins 2:2428-2466
21. Yu D, Sakurai Y, Chen CH, Chang FR, Huang L, Kashiwada Y, Lee H (2006) Anti-AIDS agents 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents. J Med Chem 49:5462-5469